A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
Clinical trial NCT03507790 · COMPLETED
Trial details
- NCT number
- NCT03507790
- Sponsor
- Cognition Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-10
- Primary completion
- 2024-05-29
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.